Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced investors.

Navigating these stocks isn’t easy, which is why StockStory helps you find Comfort In Chaos. Keeping that in mind, here is one volatile stock that could deliver huge gains and two that could just as easily collapse.

Rolling One-Year Beta: 2.15

Created by IAC’s mergers of Angie’s List and HomeAdvisor, ANGI (NASDAQ: ANGI) operates the largest online marketplace for home services in the US.

Why Are We Wary of ANGI?

Service Requests have declined by 20.6% annually over the last two years, suggesting it may need to revamp its features or user experience to stay competitive

Projected sales for the next 12 months are flat and suggest demand will be subdued

High marketing expenses suggest it needs to spend heavily on new customer acquisition to sustain momentum

Angi is trading at $12.06 per share, or 5x forward EV/EBITDA. If you’re considering ANGI for your portfolio, see our FREE research report to learn more.

Rolling One-Year Beta: 1.90

Famous for its viral Las Vegas Sphere venue, Sphere Entertainment (NYSE:SPHR) hosts live entertainment events and distributes content across various media platforms.

Why Do We Avoid SPHR?

Lackluster 8.5% annual revenue growth over the last five years indicates the company is losing ground to competitors

Poor free cash flow margin of 1.9% for the last two years limits its freedom to invest in growth initiatives, execute share buybacks, or pay dividends

Rising returns on capital show management is making relatively better investments

At $93.40 per share, Sphere Entertainment trades at 13.1x forward EV-to-EBITDA. Check out our free in-depth research report to learn more about why SPHR doesn’t pass our bar.

Rolling One-Year Beta: 2.01

Originally launched with a focus on stigmatized conditions like hair loss and sexual health, Hims & Hers Health (NYSE:HIMS) operates a consumer-focused telehealth platform that connects patients with healthcare providers for prescriptions and wellness products.

Why Does HIMS Stand Out?

Business is winning new contracts that can potentially increase in value as its customer base averaged 38.9% growth over the past two years

Free cash flow margin grew by 21.3 percentage points over the last five years, giving the company more chips to play with

Historical investments are beginning to pay off as its returns on capital are growing

Hims & Hers Health’s stock price of $25.53 implies a valuation ratio of 26.7x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.

The market’s up big this year - but there’s a catch. Just 4 stocks account for half the S&P 500’s entire gain. That kind of concentration makes investors nervous, and for good reason. While everyone piles into the same crowded names, smart investors are hunting quality where no one’s looking - and paying a fraction of the price. Check out the high-quality names we’ve flagged in our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.